Skip to Main Content
American Diabetes Association Logo Open Menu
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 49, Issue 12
1 December 2000
Diabetes Cover Image for Volume 49, Issue 12
All Issues
ISSN 0012-1797
EISSN 1939-327X
Search within issue
Organizing glucose disposal: emerging roles of the glycogen targeting subunits of protein phosphatase-1.
C B Newgard; M J Brady; R M O'Doherty; A R Saltiel
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Diabetes December 2000, Vol.49, 1967-1977. doi:https://doi.org/10.2337/diabetes.49.12.1967
Activation of glucose transport by AMP-activated protein kinase via stimulation of nitric oxide synthase.
L G Fryer; E Hajduch; F Rencurel; I P Salt; H S Hundal; D G Hardie; D Carling
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Diabetes December 2000, Vol.49, 1978-1985. doi:https://doi.org/10.2337/diabetes.49.12.1978
Baculovirus-mediated gene transfer into pancreatic islet cells.
L Ma; N Tamarina; Y Wang; A Kuznetsov; N Patel; C Kending; B J Hering; L H Philipson
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Diabetes December 2000, Vol.49, 1986-1991. doi:https://doi.org/10.2337/diabetes.49.12.1986
Early graft failure of xenogeneic islets in NOD mice is accompanied by high levels of interleukin-1 and low levels of transforming growth factor-beta mRNA in the grafts.
C A Gysemans; M Waer; D Valckx; J M Laureys; D Mihkalsky; R Bouillon; C Mathieu
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Diabetes December 2000, Vol.49, 1992-1997. doi:https://doi.org/10.2337/diabetes.49.12.1992
Suppression and acceleration of autoimmune diabetes by neutralization of endogenous interleukin-12 in NOD mice.
K Fujihira; M Nagata; H Moriyama; H Yasuda; K Arisawa; M Nakayama; S Maeda; M Kasuga; K Okumura; H Yagita; K Yokono
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Diabetes December 2000, Vol.49, 1998-2006. doi:https://doi.org/10.2337/diabetes.49.12.1998
Interferon-gamma receptor signaling is dispensable in the development of autoimmune type 1 diabetes in NOD mice.
D V Serreze; C M Post; H D Chapman; E A Johnson; B Lu; P B Rothman
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Diabetes December 2000, Vol.49, 2007-2011. doi:https://doi.org/10.2337/diabetes.49.12.2007
Dehydroepiandrosterone sulfate and beta-cell function: enhanced glucose-induced insulin secretion and altered gene expression in rodent pancreatic beta-cells.
J S Dillon; G C Yaney; Y Zhou; N Voilley; S Bowen; S Chipkin; C R Bliss; V Schultz; F C Schuit; M Prentki; D J Waxman; B E Corkey
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Diabetes December 2000, Vol.49, 2012-2020. doi:https://doi.org/10.2337/diabetes.49.12.2012
Recombinant human betacellulin promotes the neogenesis of beta-cells and ameliorates glucose intolerance in mice with diabetes induced by selective alloxan perfusion.
K Yamamoto; J Miyagawa; M Waguri; R Sasada; K Igarashi; M Li; T Nammo; M Moriwaki; A Imagawa; K Yamagata; H Nakajima; M Namba; Y Tochino; T Hanafusa; Y Matsuzawa
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Diabetes December 2000, Vol.49, 2021-2027. doi:https://doi.org/10.2337/diabetes.49.12.2021
Differential patterns of glucose-induced electrical activity and intracellular calcium responses in single mouse and rat pancreatic islets.
C M Antunes; A P Salgado; L M Rosário; R M Santos
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Diabetes December 2000, Vol.49, 2028-2038. doi:https://doi.org/10.2337/diabetes.49.12.2028
Hedgehog signaling regulation of insulin production by pancreatic beta-cells.
M K Thomas; N Rastalsky; J H Lee; J F Habener
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Diabetes December 2000, Vol.49, 2039-2047. doi:https://doi.org/10.2337/diabetes.49.12.2039
Subcellular localization, mobility, and kinetic activity of glucokinase in glucose-responsive insulin-secreting cells.
M Stubbs; S Aiston; L Agius
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Diabetes December 2000, Vol.49, 2048-2055. doi:https://doi.org/10.2337/diabetes.49.12.2048
beta-cell glucokinase deficiency and hyperglycemia are associated with reduced islet amyloid deposition in a mouse model of type 2 diabetes.
S Andrikopoulos; C B Verchere; Y Terauchi; T Kadowaki; S E Kahn
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Diabetes December 2000, Vol.49, 2056-2062. doi:https://doi.org/10.2337/diabetes.49.12.2056
Mechanism by which metformin reduces glucose production in type 2 diabetes.
R S Hundal; M Krssak; S Dufour; D Laurent; V Lebon; V Chandramouli; S E Inzucchi; W C Schumann; K F Petersen; B R Landau; G I Shulman
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Diabetes December 2000, Vol.49, 2063-2069. doi:https://doi.org/10.2337/diabetes.49.12.2063
Overexpression of glutamine: fructose-6-phosphate amidotransferase in the liver of transgenic mice results in enhanced glycogen storage, hyperlipidemia, obesity, and impaired glucose tolerance.
G Veerababu; J Tang; R T Hoffman; M C Daniels; L F Hebert, Jr; E D Crook; R C Cooksey; D A McClain
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Diabetes December 2000, Vol.49, 2070-2078. doi:https://doi.org/10.2337/diabetes.49.12.2070
Effects of skyrin, a receptor-selective glucagon antagonist, in rat and human hepatocytes.
J C Parker; R K McPherson; K M Andrews; C B Levy; J S Dubins; J E Chin; P V Perry; B Hulin; D A Perry; T Inagaki; K A Dekker; K Tachikawa; Y Sugie; J L Treadway
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Diabetes December 2000, Vol.49, 2079-2086. doi:https://doi.org/10.2337/diabetes.49.12.2079
Paradoxical effect of troglitazone in normal animals: enhancement of adipocyte but reduction of liver insulin sensitivity.
M K Dea; G W Van Citters; M Ader; S D Mittelman; A L Sunehag; R N Bergman
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Diabetes December 2000, Vol.49, 2087-2093. doi:https://doi.org/10.2337/diabetes.49.12.2087
A high fasting plasma insulin concentration predicts type 2 diabetes independent of insulin resistance: evidence for a pathogenic role of relative hyperinsulinemia.
C Weyer; R L Hanson; P A Tataranni; C Bogardus; R E Pratley
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Diabetes December 2000, Vol.49, 2094-2101. doi:https://doi.org/10.2337/diabetes.49.12.2094
Impaired oxidation of plasma-derived fatty acids in type 2 diabetic subjects during moderate-intensity exercise.
E E Blaak; D P van Aggel-Leijssen; A J Wagenmakers; W H Saris; M A van Baak
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Diabetes December 2000, Vol.49, 2102-2107. doi:https://doi.org/10.2337/diabetes.49.12.2102
Thiazolidinediones inhibit the expression of beta3-adrenergic receptors at a transcriptional level.
E Bakopanos; J E Silva
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Diabetes December 2000, Vol.49, 2108-2115. doi:https://doi.org/10.2337/diabetes.49.12.2108
Longitudinal compensation for fat-induced insulin resistance includes reduced insulin clearance and enhanced beta-cell response.
S D Mittelman; G W Van Citters; S P Kim; D A Davis; M K Dea; M Hamilton-Wessler; R N Bergman
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Diabetes December 2000, Vol.49, 2116-2125. doi:https://doi.org/10.2337/diabetes.49.12.2116
A model to explore the interaction between muscle insulin resistance and beta-cell dysfunction in the development of type 2 diabetes.
F Mauvais-Jarvis; A Virkamaki; M D Michael; J N Winnay; A Zisman; R N Kulkarni; C R Kahn
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Diabetes December 2000, Vol.49, 2126-2134. doi:https://doi.org/10.2337/diabetes.49.12.2126
Prandial glucose effectiveness and fasting gluconeogenesis in insulin-resistant first-degree relatives of patients with type 2 diabetes.
M F Nielsen; B Nyholm; A Caumo; V Chandramouli; W C Schumann; C Cobelli; B R Landau; R A Rizza; O Schmitz
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Diabetes December 2000, Vol.49, 2135-2141. doi:https://doi.org/10.2337/diabetes.49.12.2135
Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.
M Lepore; S Pampanelli; C Fanelli; F Porcellati; L Bartocci; A Di Vincenzo; C Cordoni; E Costa; P Brunetti; G B Bolli
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Diabetes December 2000, Vol.49, 2142-2148. doi:https://doi.org/10.2337/diabetes.49.12.2142
Impaired in vivo stimulation of lipolysis in adipose tissue by selective beta2-adrenergic agonist in obese adolescent girls.
S Enoksson; M Talbot; F Rife; W V Tamborlane; R S Sherwin; S Caprio
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Diabetes December 2000, Vol.49, 2149-2153. doi:https://doi.org/10.2337/diabetes.49.12.2149
Exercise and thiazolidinedione therapy normalize insulin action in the obese Zucker fatty rat.
A L Hevener; D Reichart; J Olefsky
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Diabetes December 2000, Vol.49, 2154-2159. doi:https://doi.org/10.2337/diabetes.49.12.2154
Native and modified LDL activate extracellular signal-regulated kinases in mesangial cells.
A J Jenkins; V Velarde; R L Klein; K C Joyce; K D Phillips; R K Mayfield; T J Lyons; A A Jaffa
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Diabetes December 2000, Vol.49, 2160-2169. doi:https://doi.org/10.2337/diabetes.49.12.2160
Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy.
A Ceriello; A Morocutti; F Mercuri; L Quagliaro; M Moro; G Damante; G C Viberti
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Diabetes December 2000, Vol.49, 2170-2177. doi:https://doi.org/10.2337/diabetes.49.12.2170
Diabetes in the Goto-Kakizaki rat is accompanied by impaired insulin-mediated myosin-bound phosphatase activation and vascular smooth muscle cell relaxation.
O A Sandu; L Ragolia; N Begum
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Diabetes December 2000, Vol.49, 2178-2189. doi:https://doi.org/10.2337/diabetes.49.12.2178
APOE polymorphisms and the development of diabetic nephropathy in type 1 diabetes: results of case-control and family-based studies.
S Araki; D K Moczulski; L Hanna; L J Scott; J H Warram; A S Krolewski
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Diabetes December 2000, Vol.49, 2190-2195. doi:https://doi.org/10.2337/diabetes.49.12.2190
A common promoter variant of the leptin gene is associated with changes in the relationship between serum leptin and fat mass in obese girls.
C Le Stunff; C Le Bihan; N J Schork; P Bougnères
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Diabetes December 2000, Vol.49, 2196-2200. doi:https://doi.org/10.2337/diabetes.49.12.2196
Parental transmission of type 2 diabetes: the Framingham Offspring Study.
J B Meigs; L A Cupples; P W Wilson
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Diabetes December 2000, Vol.49, 2201-2207. doi:https://doi.org/10.2337/diabetes.49.12.2201
Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships.
D Dabelea; R L Hanson; R S Lindsay; D J Pettitt; G Imperatore; M M Gabir; J Roumain; P H Bennett; W C Knowler
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Diabetes December 2000, Vol.49, 2208-2211. doi:https://doi.org/10.2337/diabetes.49.12.2208
Further evidence for a susceptibility locus for type 2 diabetes on chromosome 20q13.1-q13.2.
T Klupa; M T Malecki; M Pezzolesi; L Ji; S Curtis; C D Langefeld; S S Rich; J H Warram; A S Krolewski
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Diabetes December 2000, Vol.49, 2212-2216. doi:https://doi.org/10.2337/diabetes.49.12.2212
Non-class II HLA gene associated with type 1 diabetes maps to the 240-kb region near HLA-B.
S Nejentsev; Z Gombos; A P Laine; R Veijola; M Knip; O Simell; O Vaarala; H K Akerblom; J Ilonen
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Diabetes December 2000, Vol.49, 2217-2221. doi:https://doi.org/10.2337/diabetes.49.12.2217
Cd36 and molecular mechanisms of insulin resistance in the stroke-prone spontaneously hypertensive rat.
M Collison; A M Glazier; D Graham; J J Morton; M H Dominiczak; T J Aitman; J M Connell; G W Gould; A F Dominiczak
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Diabetes December 2000, Vol.49, 2222-2226. doi:https://doi.org/10.2337/diabetes.49.12.2222
Système International (SI) Units Table
Management of Latent Autoimmune Diabetes in Adults: A Consensus Statement From an International Expert Panel
713-P: Is There a Correct Time to Measure Fasting Blood Sugar in Persons with Type 2 Diabetes Melitus?
From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus
Mechanisms of Pancreatic β-Cell Death in Type 1 and Type 2 Diabetes: Many Differences, Few Similarities
  • Online ISSN 1939-327X
  • Print ISSN 0012-1797

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept